Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients

被引：9
|
作者：
Oh, Yun Kyu [1 ,2 ]
Park, Hayne Cho [3 ]
Ryu, Hyunjin [1 ,4 ]
Kim, Yong-Chul [1 ,4 ]
Oh, Kook-Hwan [1 ,4 ]
机构：
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt, Boramae Med Ctr, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
[3] Hallym Univ, Dept Internal Med, Kangnam Sacred Heart Hosp, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
KOREAN JOURNAL OF INTERNAL MEDICINE | 2021年 / 36卷 / 04期
关键词：
Autosomal dominant polycystic kidney disease; PKD1; PKD2; Disease progression; Tolvaptan; VOLUME; PROGRESSION; MECHANISMS; TOLVAPTAN; GENOTYPE; OUTCOMES; ADPKD; RISK; MUTATIONS; MORTALITY;
D O I：
10.3904/kjim.2021.176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease 1 (PKD1) and PKD2 have been identified as genes related to ADPKD and their significance in the molecular pathology of the disease has been studied. A disease-modifying drug has been approved; therefore, it has become important to identify patients at a high risk of kidney disease progression. Genetic tests, image analysis methods, and clinical factors for kidney disease progression prediction have been established. This review describes genetic and clinical characteristics, and discusses ongoing studies in Korean ADPKD patients.
引用
收藏
页码：767 / 779
页数：13
相关论文
共 50 条
  • [31] Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease
    Elliott, Mark D.
    James, Leslie C.
    Simms, Emily L.
    Sharma, Priyana
    Girard, Louis P.
    Cheema, Kim
    Elliott, Meghan J.
    Lauzon, Julie L.
    Chun, Justin
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [32] Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
    Park, Hanil
    Paek, Jin Hyuk
    Kim, Yaerim
    Park, Woo Yeong
    Han, Seungyeup
    Jin, Kyubok
    MEDICINE, 2022, 101 (47) : E31838
  • [33] Clinical and genetic characteristics of autosomal recessive polycystic kidney disease in Oman
    Al Alawi, Intisar
    Molinari, Elisa
    Al Salmi, Issa
    Al Rahbi, Fatma
    Al Mawali, Adhra
    Sayer, John A.
    BMC NEPHROLOGY, 2020, 21 (01)
  • [34] Clinical and genetic characteristics of autosomal recessive polycystic kidney disease in Oman
    Intisar Al Alawi
    Elisa Molinari
    Issa Al Salmi
    Fatma Al Rahbi
    Adhra Al Mawali
    John A. Sayer
    BMC Nephrology, 21
  • [35] The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait
    Ali, Hamad
    Naim, Medhat
    Senum, Sarah R.
    AlSahow, Ali
    Bahbahani, Yousif
    Abu-Farha, Mohamed
    Abubaker, Jehad
    Mohammad, Anwar
    Al-Hunayan, Adel
    Asbeutah, Akram M.
    Zayed, Mohamed
    Devarajan, Sriraman
    Hussain, Naser
    John, Sumi Elsa
    Channanath, Arshad
    Thanaraj, Thangavel Alphonse
    Al-Ali, Mohammad
    AlMousawi, Mustafa
    Al-Mulla, Fahd
    Harris, Peter C.
    CLINICAL KIDNEY JOURNAL, 2023, 16 (02) : 355 - 366
  • [36] CAPD in patients with autosomal dominant polycystic kidney disease
    Hadimeri, H
    Johansson, AC
    Haraldsson, B
    Nyberg, G
    PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (04): : 429 - 432
  • [37] Genetic heterogeneity of autosomal dominant polycystic kidney disease in Argentina
    Iglesias, DM
    Martin, RS
    Fraga, A
    Virginillo, M
    Kornblihtt, AR
    Arrizurieta, E
    Viribay, M
    SanMillan, JL
    Herrera, M
    Bernath, V
    JOURNAL OF MEDICAL GENETICS, 1997, 34 (10) : 827 - 830
  • [38] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [39] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09): : 830 - 840
  • [40] MANAGEMENT OF PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): A CLINICAL AUDIT
    Cuthbertson, Laura
    Herb, Solveig
    Pascoe, Sarah
    Kirkland, Geoffrey
    Jose, Matthew
    NEPHROLOGY, 2022, 27 : 18 - 18
12345